ATE320724T1 - Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichung - Google Patents

Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichung

Info

Publication number
ATE320724T1
ATE320724T1 AT99204607T AT99204607T ATE320724T1 AT E320724 T1 ATE320724 T1 AT E320724T1 AT 99204607 T AT99204607 T AT 99204607T AT 99204607 T AT99204607 T AT 99204607T AT E320724 T1 ATE320724 T1 AT E320724T1
Authority
AT
Austria
Prior art keywords
physical exercise
oral administration
during physical
peptide material
preparation containing
Prior art date
Application number
AT99204607T
Other languages
English (en)
Inventor
Loon Lucas Johannus Cornel Van
Antonius Johannus Wagenmakers
Andries Dirk Siemensma
Anthonie Kunst
Marcellinus Jacobus J Hakkaart
Wilhelmus Hermanus Maria Saris
Original Assignee
Kerry Group Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kerry Group Services Ltd filed Critical Kerry Group Services Ltd
Application granted granted Critical
Publication of ATE320724T1 publication Critical patent/ATE320724T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/35—Degradation products of starch, e.g. hydrolysates, dextrins; Enzymatically modified starches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Pediatric Medicine (AREA)
  • Botany (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99204607T 1999-12-30 1999-12-30 Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichung ATE320724T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99204607A EP1112693B1 (de) 1999-12-30 1999-12-30 Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung

Publications (1)

Publication Number Publication Date
ATE320724T1 true ATE320724T1 (de) 2006-04-15

Family

ID=8241130

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99204607T ATE320724T1 (de) 1999-12-30 1999-12-30 Aufbaupräparat, das kohlenhydrat- und peptidmaterial enthält und sein gebrauch als energieergänzung nach oder während körperlicher übung oder als metabolischer nährstoff für die orale verabreichung

Country Status (4)

Country Link
US (1) US6713082B2 (de)
EP (1) EP1112693B1 (de)
AT (1) ATE320724T1 (de)
DE (1) DE69930464D1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
JP2003521256A (ja) * 2000-02-01 2003-07-15 マッスルテク リサーチ アンド ディヴェロプメント インコーポレーション 無脂肪筋量及び筋力を増強するためのαリポ酸含有食物補充物質
EP1327390B1 (de) * 2001-12-04 2008-01-09 Kerry Group Services International Limited Verfahren zur Herstellung von belüfteten kohlenhydrathaltigen Produkten
GB0207830D0 (en) * 2002-04-04 2002-05-15 Mars Uk Ltd Animal composition
US20050176827A1 (en) * 2002-05-10 2005-08-11 Lee Steve S. Compositions and methods for glycogen synthesis
US7338675B2 (en) * 2002-05-10 2008-03-04 Tsi Health Sciences, Inc. Fenugreek seed bio-active compositions and methods for extracting same
ES2280796T3 (es) 2002-07-01 2007-09-16 Unilever N.V. Composicion de induccion de la saciedad.
US7648957B2 (en) * 2002-09-04 2010-01-19 Dsm Ip Assets B.V. Nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction
DE60217188T2 (de) 2002-09-06 2007-10-04 Telefonaktiebolaget Lm Ericsson (Publ) Zusammengesetzter leistungsverstärker
US20060171992A1 (en) * 2002-12-20 2006-08-03 Gerhardt Cinderella C Blood glucose regulating composition
US7288570B2 (en) * 2002-12-20 2007-10-30 Nutricia N.V. Stimulation of in vivo production of proteins
GB0313630D0 (en) * 2003-06-12 2003-07-16 Wwk Trust The Compositions for the enhanced treatment of depression
US7850989B2 (en) * 2003-06-12 2010-12-14 Provimi North America, Inc. Critical care for neonatal calves
JP2005289861A (ja) * 2004-03-31 2005-10-20 Meiji Seika Kaisha Ltd グリコーゲンの貯蔵促進用の組成物
WO2007056176A2 (en) * 2005-11-03 2007-05-18 Southwest Immunology, Inc. Compositions for preventing and reducing delayed onset muscle soreness
CN101426513B (zh) * 2006-04-21 2013-05-01 株式会社明治 含有肽作为有效成分的组合物
US20070280997A1 (en) * 2006-05-31 2007-12-06 Pacifichealth Laboratories, Inc. Composition for enhancing muscle recovery
GB0617182D0 (en) * 2006-08-31 2006-10-11 Glaxo Group Ltd Novel use
AU2007341981A1 (en) * 2006-12-29 2008-07-10 The Salk Institute For Biological Studies Methods for enhancing exercise performance
US20100173822A1 (en) * 2006-12-30 2010-07-08 The Coca-Cola Company Composition comprising saccarides & peptides & uses thereof
EP1969950A1 (de) * 2007-03-12 2008-09-17 Cargill, Incorporated Teilweise hydrolysiertes Getreideprotein
FR2938733A1 (fr) * 2008-11-21 2010-05-28 Holymark Composition administrable par voie orale,en particulier pour personne pratiquant une activite physique et complement alimentaire renfermant une telle composition
WO2010100370A1 (fr) * 2009-03-02 2010-09-10 Roquette Freres Poudre granulee de lait vegetal, procede d'obtention du lait vegetal et ses utilisations
EP2424550B1 (de) 2009-04-29 2017-06-07 Ganeden Biotech, Inc. Bakterienzellmembran formulierung
EP2327316B1 (de) * 2009-11-29 2016-11-16 Premier Nutrition Corporation Verfahren zur steigerung der muskelproteinsynthese
ES2548629T3 (es) 2010-08-24 2015-10-19 Abbott Laboratories Productos nutritivos que tienen propiedades organolépticas mejoradas
US11235008B2 (en) * 2011-03-31 2022-02-01 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CN105101812B (zh) 2013-03-08 2018-04-10 艾斯姆食品公司 大米蛋白补充剂
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
CN110868870A (zh) 2017-05-12 2020-03-06 艾斯姆食品公司 大米产物及制备它们的系统和方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3080234A (en) * 1960-12-06 1963-03-05 Pfizer & Co C Method of improving the efficiency of amino acid diets
US4042688A (en) * 1975-11-24 1977-08-16 Control Drug, Inc. Method of providing high-protein nutrition by the oral administration of a predigested protein composition
JPH0647547B2 (ja) * 1985-03-20 1994-06-22 大塚製薬株式会社 栄養補給飲食品
FI904074A7 (fi) * 1989-08-28 1991-03-01 Milupa Ag Optimoidun aminohappokoostumuksen omaavat proteiini-, peptidi- ja aminohapposeokset sekä niiden käyttö keskosten ja rintalasten ravinnon sekä äidinmaidon lisäaineiden valmistamiseksi
ATE113441T1 (de) * 1989-10-02 1994-11-15 Sandoz Nutrition Ltd Proteinhydrolysaten.
LU88371A1 (fr) * 1993-07-12 1994-04-01 Michel Urso Prof Medecin Et Ch Acides aminés essentiels renforcés
US5480865A (en) * 1994-02-25 1996-01-02 Parkinson's Charitable Trust Nutritional composition
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
ATE285685T1 (de) * 1996-04-18 2005-01-15 Arla Foods Amba Zusatz zu einem diätetischen energieträger, verwendung eines proteinhydrolysates zur herstellung eines energieträgers und ein energieträger, der einen solchen zusatz enthält
US6051236A (en) * 1998-11-12 2000-04-18 Pacifichealth Laboratories, Inc. Composition for optimizing muscle performance during exercise

Also Published As

Publication number Publication date
EP1112693B1 (de) 2006-03-22
US6713082B2 (en) 2004-03-30
DE69930464D1 (de) 2006-05-11
EP1112693A1 (de) 2001-07-04
US20010031729A1 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
DE69930464D1 (de) Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung
EA200100088A1 (ru) Готовая препаративная форма в виде микрочастиц для ингаляции
AU2003273967A1 (en) Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases
RU99105213A (ru) Применение хелатирующего агента клиохинола для производства фармацевтической композиции для лечения болезни альцгеймера
WO2001009138A3 (en) Chemokine receptor antagonists and methods of use therefor
DE60003837D1 (de) Tetrapeptid, das die funktionelle aktivität von neuronen stimuliert, dieses enthaltendes pharmakologisches mittel und seine verwendung
DE69928226D1 (de) Chemokin rezeptor antagonisten und verwndung
YU66892A (sh) Fosfoinositolglikan - peptid sa delovanjem kao insulin
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
KR860002525A (ko) 거 담 약
ATE77957T1 (de) Peptid-zusammensetzung fuer die herstellung von malaria-impfstoff, sowie fuer die vorbereitung von diagnostischen einzelteilen fuer den nachweis von malaria-aehnlichen krankheiten.
WO2003045942A3 (en) Chemokine receptor antagonists and methods of use thereof
EA200000693A1 (ru) Антагонисты хемокинного рецептора и способы их применения
WO2002068017A3 (en) Method and composition for embalming
MY136546A (en) A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
WO2002004487A3 (de) Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen
CN1060178C (zh) 新的结构改性的活性肠肽衍生物、其药物组合物及其治疗男性阳痿的应用
EP0315118A3 (de) Endothelin kodierendes DNA und dessen Verwendung
US5378823A (en) Nucleic acids encoding type I interferon variants
ES2036661T3 (es) Un metodo para preparar una preparacion farmaceutica de pie de atleta.
DE602004017512D1 (de) Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält
WO2001009119A3 (en) Chemokine receptor antagonists
CA2234936A1 (en) Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
RU96104214A (ru) Способ лечения транссудативных форм центральных хориоретинальных дистрофий
RU93016862A (ru) Водно-глицериновый комплекс (2,3-диоксипропил)-орто-титана-хлорид

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties